Serum albumin nanoparticles: problems and prospects

V Hornok - Polymers, 2021 - mdpi.com
The present paper aims to summarize the results regarding serum albumin-based
nanoparticles (NPs) for drug delivery purposes. In particular, it focuses on the relationship …

Liposome-derived nanosystems for the treatment of behavioral and neurodegenerative diseases: the promise of niosomes, transfersomes, and ethosomes for …

PC Pires, AC Paiva-Santos, F Veiga - Pharmaceuticals, 2023 - mdpi.com
Psychiatric and neurodegenerative disorders are amongst the most prevalent and
debilitating diseases, but current treatments either have low success rates, greatly due to the …

Recent advances in nanomaterials for neural applications: opportunities and challenges

N Sisubalan, R Shalini, S Ramya, BS Sivamaruthi… - …, 2023 - Taylor & Francis
Nanomedicines are promising for delivering drugs to the central nervous system, though
their precision is still being improved. Fortifying nanoparticles with vital molecules can …

Parenteral lipid-based nanoparticles for CNS disorders: integrating various facets of preclinical evaluation towards more effective clinical translation

T Ilić, JB Đoković, I Nikolić, JR Mitrović, I Pantelić… - Pharmaceutics, 2023 - mdpi.com
Contemporary trends in combinatorial chemistry and the design of pharmaceuticals
targeting brain disorders have favored the development of drug candidates with increased …

Inorganic nanomaterials versus polymer-based nanoparticles for overcoming neurodegeneration

S Martano, V De Matteis, M Cascione, R Rinaldi - Nanomaterials, 2022 - mdpi.com
Neurodegenerative disorders (NDs) affect a great number of people worldwide and also
have a significant socio-economic impact on the aging population. In this context …

Current advancements related to phytobioactive compounds based liposomal delivery for neurodegenerative diseases

KB Khot, G Gopan, A Bandiwadekar, J Jose - Ageing Research Reviews, 2023 - Elsevier
Neurodegenerative diseases are the most widely affected disease condition in an aging
population. The treatment available reduces the elevated manifestations but is ineffective …

Deeper insight into ferroptosis: association with Alzheimer's, Parkinson's disease, and brain tumors and their possible treatment by nanomaterials induced ferroptosis

VK Yadav, N Choudhary, A Gacem, RK Verma… - Redox …, 2023 - Taylor & Francis
Ferroptosis is an emerging and novel type of iron-dependent programmed cell death which
is mainly caused by the excessive deposition of free intracellular iron in the brain cells. This …

Update on Therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer's and Parkinson's disease

N Kanojia, K Thapa, G Kaur, A Sharma, V Puri… - Journal of Drug Delivery …, 2023 - Elsevier
The prevalence of neurodegenerative disorders (NDs) has increased recently, with
Parkinson's disease (PD) and Alzheimer's disease (AD) being the two utmost prevalent …

Unveiling Trends: Nanoscale Materials Sha** Emerging Biomedical Applications

KJ Hughes, J Cheng, KA Iyer, K Ralhan, M Ganesan… - 2024 - ACS Publications
The realm of biomedical materials continues to evolve rapidly, driven by innovative research
across interdisciplinary domains. Leveraging big data from the CAS Content Collection, this …

Combating Dopaminergic Neurodegeneration in Parkinson's Disease through Nanovesicle Technology

R Roy, R Paul, P Bhattacharya… - ACS Chemical …, 2023 - ACS Publications
Parkinson's disease (PD) is characterized by dopaminergic neurodegeneration, resulting in
dopamine depletion and motor behavior deficits. Since the discovery of L-DOPA, it has been …